Thromb Haemost 1983; 49(03): 162-167
DOI: 10.1055/s-0038-1657353
Original Article
Schattauer GmbH Stuttgart

Factors Influencing the Deaggregation of Human and Rabbit Platelets

R L Kinlough-Rathbone
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
J F Mustard
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
D W Perry
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
E Dejana
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
J-P Cazenave
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
M A Packham
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
,
E J Harfenist
The Department of Pathology, McMaster University, Hamilton, Canada and the Department of Biochemistry, University of Toronto, Toronto, Canada
› Author Affiliations
Further Information

Publication History

Received 14 December 1982

Accepted 09 March 1983

Publication Date:
18 July 2018 (online)

Summary

The mechanisms involved in platelet deaggregation are unclear. Washed platelets from rabbits or humans aggregated by ADP can be deaggregated by EDTA or PGI2 if the release reaction has not occurred; during deaggregation 125I-fibrinogen dissociates from the platelets. Human platelets suspended in a medium without calcium undergo the release reaction during ADP-induced aggregation; EDTA, PGE, or PGI2 do not deaggregate these platelets although EDTA displaces much of the 125I-fibrinogen that associates with them during aggregation. Rabbit platelets aggregated by low concentrations of releaseinducing stimuli (sodium arachidonate, collagen or thrombin) can be deaggregated by EDTA, PGI2 or PGE1 and 125I-fibrinogen dissociates from them; with high concentrations of collagen or thrombin, deaggregation and dissociation of l25I-fibrinogen is slower. Human platelets that have undergone the release reaction in response to thrombin, collagen or a combination of sodium arachidonate and ADP are not readily deaggregated by EDTA or PGE1. Since aggregation and fibrinogen binding involving the glycoprotein IIb/IIIa complex are readily reversed by EDTA, and since Ca2+ is required for thrombospondin binding to activated platelets, there may be a third type of platelet-platelet adherence that is not disrupted by EDTA; this type of binding plays a greater role with human than with rabbit platelets.

 
  • References

  • 1 Mustard JF, Packham MA. Factors influencing platelet function: adhesion release and aggregation. Pharmacol Rev 1970; 22: 97-187
  • 2 Reimers H-J, Kinlough-Rathbone RL, Cazenave J-P, Senyi AF, Hirsh J, Packham MA, Mustard JF. In vitro and in vivo functions of thrombin-treated platelets. Thromb Haemostas 1976; 35: 151-166
  • 3 Drummond AH. Interactions of blood platelets with biogenic amines: uptake, stimulation and receptor binding. In Platelets in biology and pathology. Gordon JL. (ed). pp. 203-239 Biomedical Press; Elsevier/ North-Holland, Amsterdam: 1976
  • 4 Packham MA, Ardlie NG, Mustard JF. Effect of adenine compounds on platelet aggregation. Am J Physiol 1969; 217: 1009-1017
  • 5 Haslam RJ. Mechanisms of blood platelet aggregation. In Physiology of hemostasis and thrombosis. Johnson SA, Seegers WH. (eds). pp. 88-112 Charles C. Thomas; Springfield, IL: 1967
  • 6 Mills DC B, Roberts GC K. Membrane active drugs and the aggregation of human blood platelets. Nature 1967; 213: 35-38
  • 7 Thomas DP. Effect of catecholamines on platelet aggregation caused by thrombin. Nature 1967; 215: 298-299
  • 8 Rao GH R, Reddy KR, White JG. The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated platelets. Prostaglandins Med 1980; 4: 385-397
  • 9 Rao GH R, Johnson GJ, White JG. Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med 1980; 5: 45-48
  • 10 Martin JF, Suggett AJ, Leach E, Moncada S. The effect of prostacyclin on platelet aggregation and disaggregation in vivo. Thromb Res 1980; 18: 749-751
  • 11 Reimers H-J, Packham MA, Kinlough-Rathbone RL, Mustard JF. Effect of repeated treatment of rabbit platelets with low concentrations of thrombin on their function, metabolism and survival. Br J Haematol 1973; 25: 675-689
  • 12 Kinlough-Rathbone RL, Mustard JF, Packham MA, Perry DW, Reimers H-J, Cazenave J-P. Properties of washed human platelets. Thromb Haemostas 1977; 37: 291-308
  • 13 Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978; 52: 453-466
  • 14 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
  • 15 Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363
  • 16 Peerschke EI, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980; 55: 841-847
  • 17 Niewiarowski S, Budzynski AZ, Morinelli TA, Brudzynski TM, Stewart GJ. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem 1981; 256: 917-925
  • 18 Harfenist EJ, Packham MA, Kinlough-Rathbone RL, Mustard JF. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. J Lab Clin Med 1981; 97: 680-688
  • 19 Hawiger J, Parkinson S, Timmons S. Prostacyclin inhibits mobilization of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature 1980; 283: 195-197
  • 20 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204
  • 21 Ardlie NG, Perry DW, Packham MA, Mustard JF. Influence of apyrase on the stability of suspensions of washed rabbit platelets. Proc Soc Exp Biol Med 1971; 136: 1021-1023
  • 22 Greenberg J, Packham MA, Cazenave J-P, Reimers H-J, Mustard JF. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest 1975; 32: 476-484
  • 23 Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228: 1757-1765
  • 24 Lawrie JS, Ross J, Kemp GD. Purification of fibrinogen and the separation of its degradation products in the presence of calcium ions. Biochem Soc Trans 1979; 7: 693-694
  • 25 McFarlane AS. Efficient trace labelling of proteins with iodine. Nature 1958; 182: 53
  • 26 Packham MA, Warrior ES, Glynn MF, Senyi AS, Mustard JF. Alterations of the response of platelets to surface stimuli by pyrazole compounds. J Exp Med 1967; 126: 171-188
  • 27 Kinlough-Rathbone RL, Reimers H-J, Mustard JF, Packham MA. Sodium arachidonate can induce platelet shape change and aggregation which are independent of the release reaction. Science 1976; 192: 1011-1012
  • 28 Davies JA, Essien EM, Cazenave J-P, Kinlough-Rathbone RL, Gent M, Mustard JF. The influence of red blood cells on the effects of aspirin or sulfinpyrazone on platelet adherence to damaged rabbit aorta. Br J Haematol 1979; 42: 283-291
  • 29 Kinlough-Rathbone RL, Packham MA, Mustard JF. The effect of prostaglandin E1 on platelet function in vitro and in vivo. Br J Haematol 1970; 19: 559-571
  • 30 Harfenist EJ, Guccione MA, Packham MA, Mustard JF. The use of the synthetic peptide, Gly-Pro-Arg-Pro, in the preparation of thrombin-degranulated rabbit platelets. Blood 1982; 59: 952-955
  • 31 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-3089
  • 32 Laudano AP, Doolittle RF. Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. Biochemistry 1980; 19: 1013-1019
  • 33 Kunicki TJ, Pidard D, Rosa J-P, Nurden AT. The formation of Ca++-dependent complexes of platelet membrane glycoproteins IIb and IIIa in solution as determined by crossed immunoelectrophoresis. Blood 1981; 58: 268-278
  • 34 Nachman RL, Leung LL K. Complex formation of platelet membrane glycoproteins lib and Ilia with fibrinogen. J Clin Invest 1982; 69: 263-269
  • 35 Hagen I, Bjemim OJ, Gogstad G, Korsmo R, Solum NO. Involvement of divalent cations in the complex between the platelet glycoproteins IIb and IIIa. Biochim Biophys Acta 1982; 701: 1-6
  • 36 Phillips DR, Jennings LK, Edwards HH. Identification of membrane proteins mediating the interaction of human platelets. J Cell Biol 1980; 88: 77-86
  • 37 Gartner TK, Williams DC, Minion FC, Phillips DR. Thrombininduced platelet aggregation is mediated by a platelet plasma membrane-bound lectin. Science 1978; 200: 1281-1283
  • 38 Gartner TK, Gerrard JM, White JG, Williams DC. Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature 1981; 289: 688-690
  • 39 Phillips DR, Jennings LK, Prasanna HR. Ca2+-mediated association of glycoprotein G (thrombin-sensitive protein, thrombospondin) with human platelets. J Biol Chem 1980; 255: 11629-11632
  • 40 Jaffe EA, Leung LL K, Nachman RL, Levin RI, Mosher DF. Thrombospondin is the endogenous lectin of human platelets. Nature 1982; 295: 246-248